Rb. Vernon et Eh. Sage, CONTRACTION OF FIBRILLAR TYPE-I COLLAGEN BY ENDOTHELIAL-CELLS - A STUDY IN-VITRO, Journal of cellular biochemistry, 60(2), 1996, pp. 185-197
The formation of microvascular sprouts during angiogenesis requires th
at endothelial cells move through an extracellular matrix. Endothelial
cells that migrate in vitro generate forces of traction that compress
(i.e., contract) and reorganize vicinial extracellular matrix, a proc
ess that might be important for angiogenic invasion and morphogenesis
in vivo. To study potential relationships between traction and angioge
nesis, we have measured the contraction of fibrillar type I collagen g
els by endothelial cells in vitro. We found that the capacity of bovin
e aortic endothelial (BAE) cells to remodel type I collagen was simila
r to that of human dermal fibroblasts-a cell type that generates high
levels of traction. Contraction of collagen by BAE cells was stimulate
d by fetal bovine serum, human plasma-derived serum, bovine serum albu
min, and the angiogenic factors phorbol myristate acetate and basic fi
broblast growth factor (bFGF). In contrast, fibronectin and immunoglob
ulin from bovine serum, several nonserum proteins, and polyvinyl pyrro
lidone (a nonproteinaceous substitute for albumin in artificial plasma
) were not stimulatory. Contraction of collagen by BAE cells was dimin
ished by an inhibitor of metalloproteinases (1,10-phenanthroline) at c
oncentrations that were not obviously cytotoxic. Zymography of protein
s secreted by BAE cells that had contracted collagen gels revealed mat
rix metalloproteinase 2. Subconfluent BAE cells that were migratory an
d proliferating were more effective contractors of collagen than were
quiescent, confluent cells of the same strain. Moreover, bovine capill
ary endothelial cells contracted collagen gels to a greater degree tha
n was seen with BAE cells. Collectively, our observations indicate tha
t traction-driven reorganization of fibrillar type I collagen by endot
helial cells is sensitive to different mediators, some of which, e.g.,
bFGF, are known regulators of angiogenesis in vivo. (C) 1996 Wiley-Li
ss, Inc.